CCL22 and glioblastoma: While most of the analyzed chemokines (listed in Section 2) were not released by ferroptotic glioblastoma cells, we detected variations for CXCL1, CCL18, CCL20, and CCL22 (Figure 4A); however, these were not significant when comparing RSL3 to RSL3/liproxstatin-1.